No Survival Benefit for Invasive Management of Stable CAD
An interim report of a US randomized trial in patients with stable coronary disease and moderate or severe ischemia concluded that there was no difference in all-cause mortality for an initial invasive strategy compared with an initial conservative strategy, with lower risk of cardiovascular mortality but higher risk of non-cardiovascular […]